Trial intelligence / Profile preview

Bingliancao lozenge for minor recurrent aphthous ulcers (gastrointestinal heat pattern) – phase II RCT

CTR20171119Phase 2Completed

Sponsor
Boji Medical Technology Co.,Ltd.
Start
Oct 2019
Countries
1
01

Overview

A Phase 2 trial of Bingliancao lozenge in aphthosis (RAS), sponsored by Boji Medical Technology Co.,Ltd.. Started Oct 2019; status: completed.

02

Drugs

Bingliancao lozenge
03

Conditions

aphthosis (RAS)

Beyond the preview

Go deeper on CTR20171119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20171119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call